Adjuvant Imatinib in High-Risk GIST: The Longer the BetterAdjuvant Imatinib in High-Risk GIST: The Longer the Better
Patients with localized, high-risk GIST fare better when treated with adjuvant imatinib. Dr. Maurie Markman looks at how longer use of targeted therapy improves outcomes even further. Medscape Genomic Medicine (Source: Medscape Today Headlines)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

How One Strain Of MRSA Becomes Resistant To Last-Line Antibiotic
Researchers have uncovered what makes one particular strain of methicillin-resistant Staphylococcus aureus (MRSA) so proficient at picking up resistance genes, such as the one that makes it resistant to vancomycin, the last line of defense for hospital-acquired infections. They report their findings in mBio®, the online open-access journal of the American Society for Microbiology, on Tuesday May 22. MRSA strains are leading causes of hospital-acquired infections in the United States, and clonal cluster 5 (CC5) is the predominant lineage responsible for these infections... (Source: Health News from Medical News Today)